⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for neurofibromas

Every month we try and update this database with for neurofibromas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform NeurofibromasNCT01275586
Neurofibromatos...
NF1
Neurofibromas
Tasigna
18 Years - Indiana University
Natural History Study of Cutaneous Neurofibromas in People With NF1NCT05581511
Neurofibromatos...
Neurofibromatos...
Neurofibromatos...
Cutaneous Neuro...
Evaluation of t...
1 Year - 100 YearsJohns Hopkins University
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)NCT06222203
Neurofibromatos...
Nerve Sheath Ne...
3 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform NeurofibromasNCT03231306
Neurofibromatos...
Plexiform Neuro...
Binimetinib
1 Year - University of Alabama at Birmingham
Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1NCT05238909
Neurofibromatos...
NF1
Neurofibromatos...
- Ann & Robert H Lurie Children's Hospital of Chicago
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)NCT06222203
Neurofibromatos...
Nerve Sheath Ne...
3 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform NeurofibromasNCT01140360
Neurofibromatos...
Neurofibromas
Gleevec
3 Years - 65 YearsIndiana University
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform NeurofibromasNCT01275586
Neurofibromatos...
NF1
Neurofibromas
Tasigna
18 Years - Indiana University
Medical Treatment of "High-Risk" NeurofibromasNCT00846430
Neurofibromatos...
Peg-Interferon ...
Celecoxib (Cele...
Temozolomide (t...
Vincristine Sul...
2 Years - 30 YearsSpectrum Health Hospitals
Medical Treatment of "High-Risk" NeurofibromasNCT00846430
Neurofibromatos...
Peg-Interferon ...
Celecoxib (Cele...
Temozolomide (t...
Vincristine Sul...
2 Years - 30 YearsSpectrum Health Hospitals
Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform NeurofibromasNCT03231306
Neurofibromatos...
Plexiform Neuro...
Binimetinib
1 Year - University of Alabama at Birmingham
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: